Skip to main content

Table 3 Between groups comparison of diabetic retinopathy progression at different study points

From: Combined phacoemulsification surgery and intravitreal triamcinolone injection versus stand-alone surgery in patients with type 2 diabetes: a prospective randomized trial

 

No DR

Mild NPDR

Moderate NPDR

Severe NPDR

Early PRD

High-risk PDR

P value (overall)

Diabetic retinopathy pre-op

IVTA group

Count

5

4

12

0

0

0

1.00

% within group

23.8%

19.0%

57.1%

0%

0%

0%

% within diabetic retinopathy

45.5%

40.0%

41.4%

0%

0%

0%

No injection group

Count

6

6

17

0

0

0

% within group

20.7%

20.7%

58.6%

0%

0%

0%

% within Diabetic retinopathy preop

54.5%

60.0%

58.6%

0%

0%

0%

Diabetic retinopathy 1-month post-op

IVTA group

Count

2

6

10

2

1

0

0.713

% within group

9.5%

28.6%

47.6%

9.5%

4.8%

0%

% within Diabetic retinopathy

28.6%

54.5%

47.6%

25.0%

33.3%

0%

No injection group

Count

5

5

11

6

2

0

% within group

17.2%

17.2%

37.9%

20.7%

6.9%

0%

% within Diabetic retinopathy

71.4%

45.5%

52.4%

75.0%

66.7%

0%

Diabetic retinopathy 3 months post-op

IVTA group

Count

2

3

13

2

1

0

0.792

% within group

9.5%

14.3%

61.9%

9.5%

4.8%

0%

% within Diabetic retinopathy

50.0%

37.5%

50.0%

28.6%

33.3%

0%

No injection group

Count

2

5

13

5

2

2

% within group

6.9%

17.2%

44.8%

17.2%

6.9%

6.9%

% within Diabetic retinopathy

50.0%

62.5%

50.0%

71.4%

66.7%

100%

Diabetic retinopathy 6 months post-op

IVTA group

Count

2

3

11

4

1

0

0.012

% within group

9.5%

14.3%

52.4%

19.0%

4.8%

0.0%

% within Diabetic retinopathy

100.0%

37.5%

68.8%

33.3%

16.7%

0.0%

No injection group

Count

0

5

5

8

5

6

% within group

0.0%

17.2%

17.2%

27.6%

17.2%

20.7%

% within Diabetic retinopathy

0.0%

62.5%

31.3%

66.7%

83.3%

100%